CBD: A Brief IntroductionApril 11, 2019
Interest in cannabidiol, or CBD, has exploded over the past months. Cannabidiol is one of the two main cannabinoids in cannabis, the other being THC. CBD, unlike THC, is not psychoactive and does not produce the same effects as THC. CBD has many different potential therapeutic uses and many patients have found pain relief, reduced anxiety, and improved sleep through CBD. Researchers across the world are currently working to better understand the mechanisms through which CBD works.
Most widely available CBD products are derived from hemp, which was recently legalized in the 2018 Farm Bill in December 2018. Hemp is a variety of Cannabis sativa that, per the 2018 Farm Bill, contains less than 0.3% THC. LeafLine Labs CBD products are not hemp derived, but rather from CBD-rich strains of cannabis. This bill also legalized products derived from hemp federally, such as CBD oils, prompting larger retailers such as CVS and Walgreens to stock CBD products. Hemp production will be tightly regulated, per the Farm Bill, and states are developing their own regulatory frameworks for hemp production as required by the new laws, though these regulations are still in their infancy and are still being developed in many cases.
The wide variety of CBD products available for sale from an ever-increasing number of sources can be daunting. One thing to consider when choosing a CBD product is that LeafLine Labs’ CBD products are subject to testing and regulations that far exceed most hemp-derived CBD products, due to the regulations of the Minnesota Medical Cannabis Program. All LeafLine Labs products must be tested for purity by an independent third party laboratory before they are sold to patients. This ensures that patients receive high quality, pharmaceutical grade medical cannabis.
Additionally, LeafLine Labs CBD products are full spectrum cannabis concentrates. This means that unlike other CBD products, which are often created from hemp distillates containing nothing but CBD. This means that they do not contain the terpenes and other naturally occurring cannabinoids and compounds that LeafLine Labs CBD products do. This limits how much they benefit from the “entourage effect”, the well documented phenomenon of terpenes maximizing the therapeutic effect of cannabinoids.
Cannabidiol therapy is an exciting branch of medical cannabis that needs to be investigated by researchers further to unlock its full potential. If you are a current LeafLine Labs patient, ask your pharmacist if a CBD product could help manage your symptoms. If you are interested in becoming a patient, click here to learn more about becoming certified as a patient under the Minnesota Medical Cannabis Program.